Integer Holdings Corporation (NYSE:ITGR) Receives $140.25 Consensus PT from Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR) have been given a consensus recommendation of “Buy” by the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $140.25.

Several research firms have commented on ITGR. Raymond James Financial cut their price target on Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research report on Friday, July 25th. Wall Street Zen raised Integer from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Wells Fargo & Company cut their price target on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research report on Friday, July 25th. Citigroup raised Integer from a “hold” rating to a “strong-buy” rating and lifted their price target for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, Truist Financial cut their price target on Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research report on Friday, July 25th.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. increased its holdings in shares of Integer by 14.7% in the first quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider’s stock valued at $796,000 after purchasing an additional 863 shares during the period. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Integer in the fourth quarter valued at approximately $208,000. Teacher Retirement System of Texas purchased a new stake in shares of Integer in the first quarter valued at approximately $579,000. Quantbot Technologies LP purchased a new stake in shares of Integer in the first quarter valued at approximately $193,000. Finally, MQS Management LLC purchased a new stake in shares of Integer in the first quarter valued at approximately $272,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Price Performance

Shares of NYSE ITGR opened at $106.82 on Wednesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41. Integer has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The firm has a market capitalization of $3.74 billion, a PE ratio of 47.06, a price-to-earnings-growth ratio of 0.84 and a beta of 1.03. The stock’s 50-day simple moving average is $111.29 and its 200-day simple moving average is $116.96.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The business had revenue of $476.00 million for the quarter, compared to analyst estimates of $464.37 million. During the same period last year, the business posted $1.30 EPS. Integer’s revenue was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, equities research analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.